Anaplastic large cell lymphoma (ALCL), ALK-negative, is a type of non-Hodgkin lymphoma characterized by the proliferation of large atypical lymphoid cells. This condition primarily affects lymph nodes but can also involve extranodal sites and solid organs. Accurate coding with ICD-10 Code C84.79 is essential for proper diagnosis, documentation, billing, and public health reporting, ensuring that healthcare providers can track and manage this aggressive malignancy effectively.
What is ICD-10 Code C84.79 for Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites?
ICD-10 Code C84.79 represents anaplastic large cell lymphoma that is ALK-negative and affects extranodal and solid organ sites. This code is used when documenting cases of ALCL that do not express the anaplastic lymphoma kinase (ALK) protein, which is significant for treatment decisions and prognosis. It is crucial for accurate clinical documentation and billing in oncology settings.
ICD-10 Code C84.79 – Clinical Definition and Explanation of Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites
Anaplastic large cell lymphoma, ALK-negative, is a rare and aggressive form of non-Hodgkin lymphoma that can arise in lymph nodes or extranodal sites, including skin, lungs, and other solid organs. The absence of ALK expression differentiates it from other subtypes, impacting treatment strategies and prognosis. Prompt diagnosis and intervention are critical due to its aggressive nature.
Key Clinical Features:
- Presence of large atypical lymphoid cells on histopathological examination.
- Commonly presents with lymphadenopathy, fever, and weight loss.
- Can involve extranodal sites such as skin, lungs, and gastrointestinal tract.
- Associated with a poor prognosis compared to ALK-positive variants.
ICD-10 Code C84.79 for Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites – SOAP Notes & Clinical Use
In clinical workflows, ICD-10 Code C84.79 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code aids in capturing the complexity of the disease, ensuring comprehensive care in both acute and chronic settings.
What Does ICD-10 Code C84.79 for Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites Mean in SOAP Notes?
ICD-10 Code C84.79 connects subjective patient reports and objective clinical findings to a formal diagnosis of anaplastic large cell lymphoma, ALK-negative. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code C84.79 – Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites
Management of anaplastic large cell lymphoma, ALK-negative, requires a multidisciplinary approach, often necessitating hospitalization for intensive treatment.
Antibiotic Therapy:
- Not applicable as this is not an infectious condition.
Supportive Care:
- Chemotherapy regimens such as CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone).
- Consideration of stem cell transplant in eligible patients.
- Management of symptoms such as pain and fever.
Infection Control:
- Standard precautions to prevent infections in immunocompromised patients.
- Monitoring for febrile neutropenia during chemotherapy.
How to Document Symptoms of Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites (ICD-10 C84.79) in SOAP Notes
Subjective:
- Patient reports persistent fatigue and unexplained weight loss.
- History of night sweats and fever over the past month.
- Notable lymphadenopathy in cervical and axillary regions.
Objective:
- Physical examination reveals enlarged lymph nodes in multiple regions.
- Laboratory tests show elevated lactate dehydrogenase (LDH) levels.
- Imaging studies indicate involvement of extranodal sites.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites (ICD-10 Code C84.79)
Assessment:
- Diagnosis of anaplastic large cell lymphoma, ALK-negative, confirmed.
- Severity classified as aggressive due to rapid progression.
- Common triggers include immunosuppression and viral infections.
Plan:
- Initiate chemotherapy with CHOP regimen.
- Educate patient on potential side effects and symptom management.
- Schedule follow-up appointments for monitoring treatment response.
Treatment & Plan Section for ICD-10 Code C84.79 – Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites
- First-line treatment includes combination chemotherapy regimens.
- Non-pharmacologic strategies involve nutritional support and psychosocial counseling.
- Monitoring includes regular imaging and laboratory tests to assess treatment efficacy.
- Follow-up practices should include scheduled visits to evaluate for recurrence.
Using ICD-10 Code C84.79 for Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites in Billing & SOAP Note Compliance
- Select accurate subcodes based on clinical severity or complications.
- Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
- Ensure treatment plans align with clinical guidelines to support justified billing.
- Only list CPT codes that are commonly billed with ICD-10 Code C84.79 based on standard medical coding practices.
Related ICD-10 Codes Often Used with Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites
- C84.70 – Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites
- C83.90 – Hodgkin lymphoma, unspecified, extranodal and solid organ sites
ICD-10 Code C84.79 in Medical Billing and Insurance for Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites
ICD-10 Code C84.79 is critical in billing for hospitalizations and treatments related to anaplastic large cell lymphoma, ALK-negative.
Billing Notes:
- Ensure comprehensive documentation of patient history and treatment plans.
- Use this code in inpatient and outpatient settings for accurate billing.
- Highlight key chart elements such as diagnostic imaging and lab results.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 85025 | Complete blood count with automated differential white blood cell count. |
| 77021 | Magnetic resonance imaging, any joint, without contrast. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C84.79 for Anaplstc lg cell lymph, ALK-neg, extrnod and solid org sites
What are the common symptoms of anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and skin lesions if extranodal sites are involved.
How is anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes or tissues to confirm the presence of atypical lymphoid cells.
What treatment options are available for ALK-negative anaplastic large cell lymphoma?
Treatment usually involves chemotherapy regimens such as CHOP, and in some cases, stem cell transplantation may be considered based on the patient's overall health and disease stage.
Is anaplastic large cell lymphoma contagious?
No, anaplastic large cell lymphoma is not contagious. It is a type of cancer that arises from lymphoid tissue and is not spread from person to person.
